PT
Protibea Therapeutics, Inc.
SEC filingOther Health Care · Georgetown, TX
Amount raised$200Ksold at filing
Total offering$11.7M$11.5M still open
Investors in the raise2count reported to the SEC
FiledAug 18, 2025first sale Jul 30, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jim MoriartyExecutive Officer, Director
Yu GeDirector
William ChamberlinExecutive Officer, Director
Harry OkenDirector
Executive officers, directors and promoters as listed on the Form D.